APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pneumococcal Vaccine

Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.

There are two types of Pneumococcal Vaccine: conjugate vaccines and polysaccharide vaccines.

23-Valent Pneumococcal Polysaccharide Vaccine (PPSV 23) is polysaccharide vaccine. Pneumococcal conjugate vaccines contain PCV 7/13 (Pfizer) and PCV10 (GSK).

Selected research

Industry Growth & Trends

Global Pneumococcal Vaccine Industry Growth and Trends Forecast to 2032

25 December 202594 pages

Choose your research edition.

Industry ResearchPneumococcal Vaccine Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Pneumococcal Vaccine Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Pneumococcal Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pneumococcal Vaccine Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Pneumococcal Vaccine Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.

There are two types of Pneumococcal Vaccine: conjugate vaccines and polysaccharide vaccines.

23-Valent Pneumococcal Polysaccharide Vaccine (PPSV 23) is polysaccharide vaccine. Pneumococcal conjugate vaccines contain PCV 7/13 (Pfizer) and PCV10 (GSK).

Read the full market overview

At present, only MSD, Sanofipasteur and CDIBP can produce PPSV 23, and they hold key technologies and patents, with high-end customers, have been formed in the monopoly position in the industry. As for PCV 13, only Pfizer can supply it. And GSK is the only one manufacturing PCV 10. However, there are some companies working on research of Pneumococcal Vaccine. Pfizer is the leader of this industry with 84% market shares.

North America is the largest consumption market of Pneumococcal Vaccine with sales market share nearly 40%. The second place is Europe, following North America with sales market share over 18%. Asia-Pacific is another important market of Pneumococcal Vaccine, enjoy nearly 16% sales market share, but the consumption experienced a sharp decrease due to approval of government departments in last few years.

Report Scope

This report provides a structured, data-driven view of the global Pneumococcal Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pneumococcal Vaccine market size, estimates, and forecasts are presented in terms of sales volume (K Doses) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pneumococcal Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pneumococcal Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Pneumococcal Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pneumococcal Vaccine Market by Company

Pfizer

GSK

MSD

Sanofipasteur

CDIBP

Pneumococcal Vaccine Segment by Type

PPSV 23

PCV 7/13

PCV 10

Pneumococcal Vaccine Segment by End User

Child

Adult

Pneumococcal Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pneumococcal Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pneumococcal Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pneumococcal Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pneumococcal Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Pneumococcal Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of PPSV 23 Table 2. Major Company of PCV 7/13 Table 3. Major Company of PCV 10 Table 4. Global Pneumococcal Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Pneumococcal Vaccine Sales by Type (2021-2026) & (K Doses) Table 6. Global Pneumococcal Vaccine Sales Market Share in Volume by Type (2021-2026) Table 7. Global Pneumococcal Vaccine Sales by Type (2021-2026) & (US$ Million) Table 8. Global Pneumococcal Vaccine Sales Market Share in Value by Type (2021-2026) Table 9. Global Pneumococcal Vaccine Price by Type (2021-2026) & (USD/Dose) Table 10. Global Pneumococcal Vaccine Sales by Type (2027-2032) & (K Doses) Table 11. Global Pneumococcal Vaccine Sales Market Share in Volume by Type (2027-2032) Table 12. Global Pneumococcal Vaccine Sales by Type (2027-2032) & (US$ Million) Table 13. Global Pneumococcal Vaccine Sales Market Share in Value by Type (2027-2032) Table 14. Global Pneumococcal Vaccine Price by Type (2027-2032) & (USD/Dose) Table 15. North America Pneumococcal Vaccine Sales by Type (2021-2026) & (K Doses) Table 16. North America Pneumococcal Vaccine Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Pneumococcal Vaccine Sales by Type (2021-2026) & (K Doses) Table 18. Europe Pneumococcal Vaccine Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Pneumococcal Vaccine Sales by Type (2021-2026) & (K Doses) Table 20. Asia-Pacific Pneumococcal Vaccine Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Pneumococcal Vaccine Sales by Type (2021-2026) & (K Doses) Table 22. Latin America Pneumococcal Vaccine Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Pneumococcal Vaccine Sales by Type (2021-2026) & (K Doses) Table 24. Middle East and Africa Pneumococcal Vaccine Sales by Type (2021-2026) & (US$ Million) Table 25. Pneumococcal Vaccine Industry Trends Table 26. Pneumococcal Vaccine Industry Drivers Table 27. Pneumococcal Vaccine Industry Opportunities and Challenges Table 28. Pneumococcal Vaccine Industry Restraints Table 29. Global Pneumococcal Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Pneumococcal Vaccine Revenue Market Share by Company (2021-2026) Table 31. Global Pneumococcal Vaccine Sales by Company (2021-2026) & (K Doses) Table 32. Global Pneumococcal Vaccine Sales Share by Company (2021-2026) Table 33. Global Pneumococcal Vaccine Market Price by Company (2021-2026) & (USD/Dose) Table 34. Global Pneumococcal Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Pneumococcal Vaccine Major Company Production Sites and Headquarters Table 36. Global Pneumococcal Vaccine Company, Product Type & Application Table 37. Global Pneumococcal Vaccine Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Pneumococcal Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Pneumococcal Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Pneumococcal Vaccine Sales by Region (2021-2026) & (K Doses) Table 42. Global Pneumococcal Vaccine Sales Market Share in Volume by Region (2021-2026) Table 43. Global Pneumococcal Vaccine Sales by Region (2021-2026) & (US$ Million) Table 44. Global Pneumococcal Vaccine Sales Market Share in Value by Region (2021-2026) Table 45. Global Pneumococcal Vaccine Sales (K Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 46. Global Pneumococcal Vaccine Sales by Region (2027-2032) & (K Doses) Table 47. Global Pneumococcal Vaccine Sales Market Share in Volume by Region (2027-2032) Table 48. Global Pneumococcal Vaccine Sales by Region (2027-2032) & (US$ Million) Table 49. Global Pneumococcal Vaccine Sales Market Share in Value by Region (2027-2032) Table 50. Global Pneumococcal Vaccine Sales (K Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2027-2032) Table 51. Global Pneumococcal Vaccine Sales by End User (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Pneumococcal Vaccine Sales by End User (2021-2026) & (K Doses) Table 53. Global Pneumococcal Vaccine Sales Market Share in Volume by End User (2021-2026) Table 54. Global Pneumococcal Vaccine Sales by End User (2021-2026) & (US$ Million) Table 55. Global Pneumococcal Vaccine Sales Market Share in Value by End User (2021-2026) Table 56. Global Pneumococcal Vaccine Price by End User (2021-2026) & (USD/Dose) Table 57. Global Pneumococcal Vaccine Sales by End User (2027-2032) & (K Doses) Table 58. Global Pneumococcal Vaccine Sales Market Share in Volume by End User (2027-2032) Table 59. Global Pneumococcal Vaccine Sales by End User (2027-2032) & (US$ Million) Table 60. Global Pneumococcal Vaccine Sales Market Share in Value by End User (2027-2032) Table 61. Global Pneumococcal Vaccine Price by End User (2027-2032) & (USD/Dose) Table 62. North America Pneumococcal Vaccine Sales by End User (2021-2026) & (K Doses) Table 63. North America Pneumococcal Vaccine Sales by End User (2021-2026) & (US$ Million) Table 64. Europe Pneumococcal Vaccine Sales by End User (2021-2026) & (K Doses) Table 65. Europe Pneumococcal Vaccine Sales by End User (2021-2026) & (US$ Million) Table 66. Asia-Pacific Pneumococcal Vaccine Sales by End User (2021-2026) & (K Doses) Table 67. Asia-Pacific Pneumococcal Vaccine Sales by End User (2021-2026) & (US$ Million) Table 68. Latin America Pneumococcal Vaccine Sales by End User (2021-2026) & (K Doses) Table 69. Latin America Pneumococcal Vaccine Sales by End User (2021-2026) & (US$ Million) Table 70. Middle East and Africa Pneumococcal Vaccine Sales by End User (2021-2026) & (K Doses) Table 71. Middle East and Africa Pneumococcal Vaccine Sales by End User (2021-2026) & (US$ Million) Table 72. Pfizer Company Information Table 73. Pfizer Business Overview Table 74. Pfizer Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 75. Pfizer Pneumococcal Vaccine Product Portfolio Table 76. Pfizer Recent Development Table 77. GSK Company Information Table 78. GSK Business Overview Table 79. GSK Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 80. GSK Pneumococcal Vaccine Product Portfolio Table 81. GSK Recent Development Table 82. MSD Company Information Table 83. MSD Business Overview Table 84. MSD Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 85. MSD Pneumococcal Vaccine Product Portfolio Table 86. MSD Recent Development Table 87. Sanofipasteur Company Information Table 88. Sanofipasteur Business Overview Table 89. Sanofipasteur Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 90. Sanofipasteur Pneumococcal Vaccine Product Portfolio Table 91. Sanofipasteur Recent Development Table 92. CDIBP Company Information Table 93. CDIBP Business Overview Table 94. CDIBP Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 95. CDIBP Pneumococcal Vaccine Product Portfolio Table 96. CDIBP Recent Development Table 97. North America Pneumococcal Vaccine Market Size Growth Rate (CAGR) by Country (K Doses): 2021 VS 2025 VS 2032 Table 98. North America Pneumococcal Vaccine Sales by Country (2021-2026) & (K Doses) Table 99. North America Pneumococcal Vaccine Sales Market Share by Country (2021-2026) Table 100. North America Pneumococcal Vaccine Sales Forecast by Country (2027-2032) & (K Doses) Table 101. North America Pneumococcal Vaccine Sales Market Share Forecast by Country (2027-2032) Table 102. North America Pneumococcal Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 103. North America Pneumococcal Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 104. North America Pneumococcal Vaccine Market Share by Country (2021-2026) Table 105. North America Pneumococcal Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 106. North America Pneumococcal Vaccine Market Share Forecast by Country (2027-2032) Table 107. Europe Pneumococcal Vaccine Market Size Growth Rate (CAGR) by Country (K Doses): 2021 VS 2025 VS 2032 Table 108. Europe Pneumococcal Vaccine Sales by Country (2021-2026) & (K Doses) Table 109. Europe Pneumococcal Vaccine Sales Market Share by Country (2021-2026) Table 110. Europe Pneumococcal Vaccine Sales Forecast by Country (2027-2032) & (K Doses) Table 111. Europe Pneumococcal Vaccine Sales Market Share Forecast by Country (2027-2032) Table 112. Europe Pneumococcal Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 113. Europe Pneumococcal Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 114. Europe Pneumococcal Vaccine Market Share by Country (2021-2026) Table 115. Europe Pneumococcal Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 116. Europe Pneumococcal Vaccine Market Share Forecast by Country (2027-2032) Table 117. Asia-Pacific Pneumococcal Vaccine Market Size Growth Rate (CAGR) by Country (K Doses): 2021 VS 2025 VS 2032 Table 118. Asia-Pacific Pneumococcal Vaccine Sales by Country (2021-2026) & (K Doses) Table 119. Asia-Pacific Pneumococcal Vaccine Sales Market Share by Country (2021-2026) Table 120. Asia-Pacific Pneumococcal Vaccine Sales Forecast by Country (2027-2032) & (K Doses) Table 121. Asia-Pacific Pneumococcal Vaccine Sales Market Share Forecast by Country (2027-2032) Table 122. Asia-Pacific Pneumococcal Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. Asia-Pacific Pneumococcal Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 124. Asia-Pacific Pneumococcal Vaccine Market Share by Country (2021-2026) Table 125. Asia-Pacific Pneumococcal Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. Asia-Pacific Pneumococcal Vaccine Market Share Forecast by Country (2027-2032) Table 127. Latin America Pneumococcal Vaccine Market Size Growth Rate (CAGR) by Country (K Doses): 2021 VS 2025 VS 2032 Table 128. Latin America Pneumococcal Vaccine Sales by Country (2021-2026) & (K Doses) Table 129. Latin America Pneumococcal Vaccine Sales Market Share by Country (2021-2026) Table 130. Latin America Pneumococcal Vaccine Sales Forecast by Country (2027-2032) & (K Doses) Table 131. Latin America Pneumococcal Vaccine Sales Market Share Forecast by Country (2027-2032) Table 132. Latin America Pneumococcal Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Latin America Pneumococcal Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 134. Latin America Pneumococcal Vaccine Market Share by Country (2021-2026) Table 135. Latin America Pneumococcal Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Latin America Pneumococcal Vaccine Market Share Forecast by Country (2027-2032) Table 137. Middle East and Africa Pneumococcal Vaccine Market Size Growth Rate (CAGR) by Country (K Doses): 2021 VS 2025 VS 2032 Table 138. Middle East and Africa Pneumococcal Vaccine Sales by Country (2021-2026) & (K Doses) Table 139. Middle East and Africa Pneumococcal Vaccine Sales Market Share by Country (2021-2026) Table 140. Middle East and Africa Pneumococcal Vaccine Sales Forecast by Country (2027-2032) & (K Doses) Table 141. Middle East and Africa Pneumococcal Vaccine Sales Market Share Forecast by Country (2027-2032) Table 142. Middle East and Africa Pneumococcal Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Middle East and Africa Pneumococcal Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 144. Middle East and Africa Pneumococcal Vaccine Market Share by Country (2021-2026) Table 145. Middle East and Africa Pneumococcal Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Middle East and Africa Pneumococcal Vaccine Market Share Forecast by Country (2027-2032) Table 147. Key Raw Materials Table 148. Raw Materials Key Suppliers Table 149. Pneumococcal Vaccine Distributors List Table 150. Pneumococcal Vaccine Customers List Table 151. Research Programs/Design for This Report Table 152. Authors List of This Report Table 153. Secondary Sources Table 154. Primary Sources List of Figures Figure 1. Pneumococcal Vaccine Image Figure 2. Global Pneumococcal Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pneumococcal Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Pneumococcal Vaccine Sales (2021-2032) & (K Doses) Figure 5. PPSV 23 Image Figure 6. Global PPSV 23 Sales YoY Growth (2021-2032) & (K Doses) Figure 7. PCV 7/13 Image Figure 8. Global PCV 7/13 Sales YoY Growth (2021-2032) & (K Doses) Figure 9. PCV 10 Image Figure 10. Global PCV 10 Sales YoY Growth (2021-2032) & (K Doses) Figure 11. Global Pneumococcal Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Pneumococcal Vaccine Market Share by Type 2025 VS 2032 Figure 13. North America Pneumococcal Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. North America Pneumococcal Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Europe Pneumococcal Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Europe Pneumococcal Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Pneumococcal Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Pneumococcal Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Latin America Pneumococcal Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Pneumococcal Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Pneumococcal Vaccine Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Pneumococcal Vaccine Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Pneumococcal Vaccine Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Child Image Figure 26. Global Child Sales YoY Growth (2021-2032) & (K Doses) Figure 27. Adult Image Figure 28. Global Adult Sales YoY Growth (2021-2032) & (K Doses) Figure 29. Global Pneumococcal Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Pneumococcal Vaccine Market Share by Application 2025 VS 2032 Figure 31. North America Pneumococcal Vaccine Sales Market Share in Volume by Application in 2025 Figure 32. North America Pneumococcal Vaccine Sales Market Share in Value by Application in 2025 Figure 33. Europe Pneumococcal Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. Europe Pneumococcal Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Pneumococcal Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Pneumococcal Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Latin America Pneumococcal Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Pneumococcal Vaccine Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Pneumococcal Vaccine Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Pneumococcal Vaccine Sales Market Share in Value by Application in 2025 Figure 41. North America Pneumococcal Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Doses) Figure 42. North America Pneumococcal Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Pneumococcal Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Pneumococcal Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Pneumococcal Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Doses) Figure 46. Europe Pneumococcal Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Pneumococcal Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Pneumococcal Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Pneumococcal Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Doses) Figure 50. Asia-Pacific Pneumococcal Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Pneumococcal Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Pneumococcal Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Pneumococcal Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Doses) Figure 54. Latin America Pneumococcal Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Pneumococcal Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Pneumococcal Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Pneumococcal Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Doses) Figure 58. Middle East and Africa Pneumococcal Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Pneumococcal Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Pneumococcal Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Pneumococcal Vaccine Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Pneumococcal Vaccine Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • PPSV 23
  • PCV 7/13
  • PCV 10
Applications
  • Child
  • Adult
Companies covered
  • Pfizer
  • GSK
  • MSD
  • Sanofipasteur
  • CDIBP

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pneumococcal Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Pneumococcal Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Pneumococcal Vaccine Market by Type
  6. 1.3.1 PPSV 23
  7. 1.3.2 PCV 7/13
  8. 1.3.3 PCV 10
  9. 1.4 Global Pneumococcal Vaccine Market Size by Type
  10. 1.4.1 Global Pneumococcal Vaccine Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Pneumococcal Vaccine Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Pneumococcal Vaccine Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Pneumococcal Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Pneumococcal Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Pneumococcal Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Pneumococcal Vaccine Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Pneumococcal Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Pneumococcal Vaccine Industry Trends
  2. 2.2 Pneumococcal Vaccine Industry Drivers
  3. 2.3 Pneumococcal Vaccine Industry Opportunities and Challenges
  4. 2.4 Pneumococcal Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Pneumococcal Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Pneumococcal Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Pneumococcal Vaccine Price (2021-2026)
  4. 3.4 Global Pneumococcal Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pneumococcal Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Pneumococcal Vaccine Company, Product Type & Application
  7. 3.7 Global Pneumococcal Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pneumococcal Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pneumococcal Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pneumococcal Vaccine Tier 1, Tier 2, and Tier 3
4 Pneumococcal Vaccine Regional Status and Outlook
  1. 4.1 Global Pneumococcal Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Pneumococcal Vaccine Historic Market Size by Region
  3. 4.2.1 Global Pneumococcal Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Pneumococcal Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Pneumococcal Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Pneumococcal Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Pneumococcal Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Pneumococcal Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Pneumococcal Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pneumococcal Vaccine by Application
  1. 5.1 Pneumococcal Vaccine Market by End User
  2. 5.1.1 Child
  3. 5.1.2 Adult
  4. 5.2 Global Pneumococcal Vaccine Market Size by End User
  5. 5.2.1 Global Pneumococcal Vaccine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Pneumococcal Vaccine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Pneumococcal Vaccine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by End User
  9. 5.3.1 North America Pneumococcal Vaccine Sales Breakdown by End User (2021-2026)
  10. 5.3.2 Europe Pneumococcal Vaccine Sales Breakdown by End User (2021-2026)
  11. 5.3.3 Asia-Pacific Pneumococcal Vaccine Sales Breakdown by End User (2021-2026)
  12. 5.3.4 South America Pneumococcal Vaccine Sales Breakdown by End User (2021-2026)
  13. 5.3.5 Middle East and Africa Pneumococcal Vaccine Sales Breakdown by End User (2021-2026)
6 Company Profiles
  1. 6.1 Pfizer
  2. 6.1.1 Pfizer Company Information
  3. 6.1.2 Pfizer Business Overview
  4. 6.1.3 Pfizer Pneumococcal Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Pfizer Pneumococcal Vaccine Product Portfolio
  6. 6.1.5 Pfizer Recent Developments
  7. 6.2 GSK
  8. 6.2.1 GSK Company Information
  9. 6.2.2 GSK Business Overview
  10. 6.2.3 GSK Pneumococcal Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 GSK Pneumococcal Vaccine Product Portfolio
  12. 6.2.5 GSK Recent Developments
  13. 6.3 MSD
  14. 6.3.1 MSD Company Information
  15. 6.3.2 MSD Business Overview
  16. 6.3.3 MSD Pneumococcal Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 MSD Pneumococcal Vaccine Product Portfolio
  18. 6.3.5 MSD Recent Developments
  19. 6.4 Sanofipasteur
  20. 6.4.1 Sanofipasteur Company Information
  21. 6.4.2 Sanofipasteur Business Overview
  22. 6.4.3 Sanofipasteur Pneumococcal Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Sanofipasteur Pneumococcal Vaccine Product Portfolio
  24. 6.4.5 Sanofipasteur Recent Developments
  25. 6.5 CDIBP
  26. 6.5.1 CDIBP Company Information
  27. 6.5.2 CDIBP Business Overview
  28. 6.5.3 CDIBP Pneumococcal Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 CDIBP Pneumococcal Vaccine Product Portfolio
  30. 6.5.5 CDIBP Recent Developments
7 North America by Country
  1. 7.1 North America Pneumococcal Vaccine Sales by Country
  2. 7.1.1 North America Pneumococcal Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Pneumococcal Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Pneumococcal Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Pneumococcal Vaccine Market Size by Country
  6. 7.2.1 North America Pneumococcal Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Pneumococcal Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Pneumococcal Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Pneumococcal Vaccine Sales by Country
  2. 8.1.1 Europe Pneumococcal Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Pneumococcal Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Pneumococcal Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Pneumococcal Vaccine Market Size by Country
  6. 8.2.1 Europe Pneumococcal Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Pneumococcal Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Pneumococcal Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Pneumococcal Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Pneumococcal Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Pneumococcal Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Pneumococcal Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Pneumococcal Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Pneumococcal Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Pneumococcal Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Pneumococcal Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Pneumococcal Vaccine Sales by Country
  2. 10.1.1 South America Pneumococcal Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Pneumococcal Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Pneumococcal Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Pneumococcal Vaccine Market Size by Country
  6. 10.2.1 South America Pneumococcal Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Pneumococcal Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Pneumococcal Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Pneumococcal Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Pneumococcal Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Pneumococcal Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Pneumococcal Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Pneumococcal Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Pneumococcal Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Pneumococcal Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Pneumococcal Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Pneumococcal Vaccine Value Chain Analysis
  2. 12.1.1 Pneumococcal Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Pneumococcal Vaccine Production Mode & Process
  7. 12.2 Pneumococcal Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Pneumococcal Vaccine Distributors
  10. 12.2.3 Pneumococcal Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst